Advanced Search
Contact | Corporate | Help

Daily news email for August 16, 2012 | Click here for updated news

SourceSolution News
We want to hear from you! Click here let us know how we can make this news email better.

Manage projects more efficiently. Try PlanIt free for 15 days.

Create quality questionnaires and RFPs more quickly, weight responses and manage suppliers.

Discounted advertising rates on www.sourcesolution.com for all BIOCOM members starting at $100/month

Use PlanIt as your next deal room! Click here to learn more.

 b3c newswire
ZZ Biotech Initiates Phase 1 Study with 3K3A-APC for the Treatment of Acute Ischemic Stroke

AiCuris Promising Drugs Against Herpes Simplex (AIC316) and Human Cytomegalovirus (Letermovir, ...

CEVEC Licenses its Proprietary Human Cell Lines to Paragon Bioservices, Inc.

Cambridge Research Biochemicals Signs Deal with LI-COR Biosciences for Infrared Dye Labelled ...

2. Laupheimer Zelltage Attracts Top Scientists to Discuss Recent Advances in Biomanufacturing

 BioSpace
Pharmalucence, Inc. Announces FDA Approval and Orphan Drug Designation for Use of Sulfur Colloid Injection to Locate Lymph Nodes in Malignant Melanoma Patients

Medicis' Skin Drug Gets Generic Threat From

Gilead Sciences, Inc. Warned by Democrats Over "Quad" Pricing

Myrexis, Inc. Announces Death of Chief Executive Officer Trailblazing Biotechnology Industry Veteran and Patient Advocate

New Technology Could Improve Treatment for Diabetes, Other Disorders, Texas A&M University Study

BioSpace - Breaking News
Sunshine Biopharma, Inc. Announces Submission of an Adva-27a Manuscript for Publication in a Peer-Reviewed Scientific Journal

Isconova's Adjuvant Matrix-M Approved by FDA for an IND Clinical Trial

Senesco Technologies, Inc. Announces that SNS01-T Showed Good Tolerability and Stable Disease in Newly Completed First Cohort of Phase 1b/2a Multiple Myeloma Trial

Genocea Biosciences Initiates a Phase 1/2a Study With Its Therapeutic Vaccine Candidate for Herpes Simplex Virus-2 (HSV-2)

Curis, Inc. and Debiopharm Announce Initiation of Phase I-II Clinical Study of HSP90 Inhibitor Debio 0932

Biotech News - Business Wire
Samenvatting: Grote namen in industriële biotechnologie discussiëren over mondiale bio-economische ontwikkeling op EuropaBIO's EFIB 2012

Quotient Biodiagnostics Signs 36 Month Agreement with the Premier Healthcare Alliance to Supply Blood Bank Reagents to Its 2,600 Member Hospitals

Zephyr Technology to Introduce Cutting-Edge PSM Systems Into mHealth Market Following Significant New Investment

Fluidigm Prices $52.2 Million Public Offering of Common Stock

Resumen: Las empresas más destacadas de la energía biotecnológica industrial presentarán el panorama del desarrollo de la la bioeconomía global durante EFIB 2012 de EuropaBio

 Biotech News - PR Newswire
MarketsandMarkets: The Global Ophthalmology Drugs and Devices Market is Expected to Reach $52.4 Billion by 2017

CBI's 9th Annual Forum on Formulary and Reimbursement Strategies: Payer Perspectives

Solos Endoscopy Posts Total Assets of $2,426,883 for Period Ended June 30, 2012

Former FDA Inspectors Train Medical Device, Pharmaceutical Companies How to Prepare for FDA Inspections of Their Quality Systems

Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Biotechnology - Moreover
Analysis of Relative Performance in the Biotechnology Industry for Shares of Incyte (INCY, ONXX, ALKS, SPPI, MITI)

Top 5 Companies in the Biotechnology Industry with the Best Relative Performance (CPHD, IMGN, HGSI, SGEN, RIGL)

NIH Translational Center Should Raise All Boats, BIO Says

Immunogen, inc. reports second quarter fiscal year 2012 financial results and provides quarterly update

Biotechnology to be 21st-century industry: Life Tech CEO

 Burrill Report
Innovation Bank Proposed

China Invests in U.K. Diagnostics Startup

Alzheimer's Drug Bapineuzumab Fails in Second Trial

Nanobiotix teams up with PharmaEngine in Nanomedicine Deal

Pharma Heads Back to School

 CenterWatch - Clinical Trials
Sanofi's $20 billion Genzyme buy could fuel a big pharma-biotechnology acquisition trend

New Quintiles initiative saves investigative sites the time, and cost, of patient recruitment advertising

Technology companies adapt interactive video concepts for clinical trial informed consent

CRI buys Lifetree, combining investigative sites on both coasts and across all trial phases

New $1b NIH center will tackle early-stage drug development to ease industry risk of failure
Clinical Trials - Business Wire
Excelsior Medical Announces Issuance of Second U.S. Patent on SwabFlush

Origin Healthcare Solutions Adds Two Senior Executives to Leadership Team

Research and Markets: Leiomyosarcoma Global Clinical Trials Review, H2, 2012

Research and Markets: Congestive Heart Failure (Heart Failure) Global Clinical Trials Review, H1, 2012

Radiology Quality Institute eBook Defines Quality Standards in Radiology

 Clinical Trials - PR Newswire
Kuoni Announces Participants in the Holiday Health Experiment

IDRI and Medicago Announce FDA Authorization to Initiate a Phase 1 Clinical Trial for an H5N1 Vaccine with GLA Adjuvant

AspenBio Pharma Focuses Resources on Development of AppyScore Clinical Diagnostic Test

WVU Health Sciences Gets $19.6 Million Research Grant From NIH

New Data Suggests Low-Dose Molecular Breast Imaging is Possible for Single-Head Imaging Systems

 CNN Top Stories
$1M ticket still hasn't been claimed

Photos: Flooding in the Philippines

Opinion: Can hyper-partisanship end

Suspect charged in FRC shooting

WikiLeaks founder gets asylum
Contract Pharma
IMS Health Acquires TTC

TG, Rhizen in Global Development Pact

Biogen, Regulus in microRNA Biomarker Pact

WuXi PharmaTech's Facility Receives GLP Certificate

Morphotek Opens Manufacturing Plant

 FDA Drugs- What's New
FDA Drug Safety Communication: Codeine use in certain children after tonsillectomy and/or adenoidectomy may lead to rare, but life-threatening adverse events or death

Comunicado de la FDA sobre la seguridad de los medicamentos: Riesgo de convulsiones en pacientes con esclerosis múltiple que toman Ampyra (dalfampridine)

Comunicado de la FDA sobre la seguridad de los medicamentos: Riesgo de convulsiones en pacientes con esclerosis múltiple que toman Ampyra (dalfampridine)

FDA Drug Safety Communication: Seizure risk for multiple sclerosis patients who take Ampyra (dalfampridine)

Comunicado de la FDA sobre la seguridad de los medicamentos: Nueva información sobre la prolongación del intervalo QT con ondansetrón (Zofran)

 FDA News - Business Wire
BioTime and OncoCyte Corporation Publish Data on the Gene COL10A1 as a Marker and Potential Diagnostic for a Wide Array of Human Cancers

Pharmalucence Announces FDA Approval and Orphan Drug Designation for Use of Sulfur Colloid Injection to Locate Lymph Nodes in Malignant Melanoma Patients

CryoPen Unveils Revolutionary New Cervical Cancer Treatment

United Health Products Epic Wound Care Inc. Receives 510K approval on its Hemostyp Trauma Gauze

Vasomedical Announces 48.7% Increase in Revenue for the Second Quarter 2012
FDA Press Releases
FDA warns of risk of death from codeine use in some children following surgeries

FDA approves vaccines for the 2012-2013 influenza season

FDA approves vaccine formulation for the 2012-2013 influenza season

FDA approves Lucentis to treat diabetic macular edema

FDA approves Marqibo to treat rare type of leukemia

 FDA Vaccines, Blood and Biologics - What's New
Black Widow Spider Antivenin (Latrodectus mactans)(Equine) Packaged Lot 0585Z: Information about Expiration Date and Use

Cord Blood Banking - Information for Consumers

Package Insert - Twinrix

Direct Recall Classification Program

Draft Guidance for Industry: Amendment to Guidance for Industry: Revised Preventive Measures to Reduce the Possible Risk of Transmission of Creutzfeldt-Jakob Disease and Variant Creutzfeldt-Jakob Disease by Blood and Blood Products

 FierceBiotech
Idenix shares eviscerated as clinical hold raises tox fears for hep C drug

Upbeat PhIII results bolster Medivation's big plans for enzalutamide

Promising colitis data build blockbuster case for Pfizer's tofacitinib

R&D experts applaud new initiative to validate biomedical studies

Open-innovation projects turn old R&D wisdom 'on its head'
FierceBiotech IT
IMS bags planning tech for clinical trials with TTC buyout

Big data analytics bolsters hunt for elusive Huntington's drugs

Quintiles gains genomic, bioinformatics know-how in buyout

U.K. scientists tap into ehealth research with Centers of Excellence

Merck to draw on social network for psoriasis patients

 FierceBiotech Research
Dana-Farber, Broad Institute identify CYCLOPS gene class in cancer fight

Cephalon cancer drug, in combo therapy, kills multiple myeloma cells in mice

Regulus, AstraZeneca team up in microRNA preclinical partnership

Prosthetic retina restores partial sight to blind mice

Gene offers tantalizing leukemia target

 FiercePharma
Abbott CEO's paycheck bigger than its tax bill, study says

Icahn pick makes Forest board cut

FTC gives blessing to drug shortage effort

Watson sues FDA for delay of generic Actos launch

Lawmakers pressure Gilead on Quad price ahead of approval
FiercePharma Manufacturing
West-Ward plant problems undermine Hikma earnings

Morphotek turns to manufacturing with new plant

FDA turns to Merck on Sanofi cancer drug shortage

GPhA drug shortage plan passes FTC smell test

Internet drug dealer gets 10 years but feds want his Chinese boss

 FierceVaccines
Merck's Gardasil the HPV vax of choice in Scotland

Heart disease vaccine steps closer

Antigen Discovery receives $2.5M grant for malaria vax

Feds cut ebola vax funding

FDA approves 6 flu vaccines

 Health News - BizJournals.com
Hearing tackles what nonprofit hospitals do for tax-exempt status

Triangle schools land millions in research grants

Dr. Larry Miller to receive Julio Palmaz Award

DARA BioSciences inks distribution deal with Seyer Pharmatec

Nonprofit hospital hearing addresses charity care, tax-exempt status
Health News - CNBC
S. Africa police fire at striking mine workers

Perrigo fiscal 4Q profit climbs but shares tumble

EU considering cigarette logo ban to deter smoking

Idenix tumbles on hepatitis drug safety concerns

Edelman on the Fine Art of Investing

 Health News - Fox Business
Employers Grateful for Proposed Tax Breaks, But Still Scared

Employers Grateful for Proposed Tax Breaks, Still Scared

Insmed Shares Drop as FDA Halts Study After Rat Test Results

Week Ahead: A Flood Of 2Q Earnings

Pfizer Drug Raises Heart Attack Risk: Study

 Inside Industry - Gen
It's Tool Time for VCs

Brain & Behavior Research Foundation Invests $11.9 Million in NARSAD Grants for a New Generation of Mental Health Research

AstraZeneca Partners on miRNA Inhibitors

Firms Flock to Epic's CTC Platform

Elan to Cut Loose its Discovery Subsidiary
Marketwire - Pharma and Biotech
BioCentury This Week to Celebrate Its 100th Show This Sunday

Charles Hensley, Ph.D., Inventor of Zicam(R) Cold Remedy, Creates Itonis Pharmaceuticals, a New Division of Itonis, Inc.

International Stem Cell Corp Announces World-Renowned Scientists Join as Advisors on Parkinson's Disease Program

Totally Green Makes Management and Board Appointments to Support New Go-to-Market Service Model

Dr. Harold Schoenhaus Joins the Scientific Advisory Board of Alliqua

 MassBio News
GNS Healthcare And CHDI Foundation Collaborate To Build Computer Model Of Huntington's Disease

Stericycle Hosting Four FREE DOT Hazmat Trainings for MassBio Members Via Webex

Stericycle Adds SteriSafe for MassBio Members

FierceBiotech will announce 2012 "Fierce 15" at BioPharm America in September

State, Local and Industry Officials Join KeraFAST to Open New Headquarters in Boston, MA

 Medical Pharma - PR Newswire
Creating a future of personalized medicine: U-M forms nonprofit joint venture for advanced DNA diagnostics

UPS & NGO partners help curb cholera crisis in Mali

Interboro RHIO and NYC Health and Hospitals Corporation Join the Statewide Health Information Network of New York

Retia Medical Raises $7 Million to Develop Accurate, Less-Invasive Cardiovascular Monitor

Chronic Heart Failure (CHF) Therapeutics - Pipeline Assessment and Market Forecasts to 2019
National Center for Biotechnology Information
GenBank Submission Tools Announcements

GTR News

GEO Series Releases

ClinVar News and Announcements

Behind The Headlines - Health News from NHS Choices

 Nature Biotechnology
Reply to In support of the European Union biosimilar framework

In support of the European Union biosimilar framework

It's the problem, stupid!

Adult stem cell therapies walk the line

Biotech weathers 2Q12 slump

 New York Times- Biotechnology
Novel Blood Treatment Lures Athletes in Pain to Germany

Athletes With Chronic Pain Turn to Novel Blood Treatment

Human Genome Sciences Rejects A $2.59 Billion Bid From Glaxo

Craig Venter’s Bugs Might Save the World

Study Backs Continuous Prostate Cancer Treatment
New York Times- Pharmaceuticals
Pfizer Animal Health Unit Files for I.P.O.

Beware the Nocebo Effect

Amgen, Citing Weak Results, Halts Study of Pancreatic Cancer Drug

Bristol Executive Is Accused of Inside Deals

Prescription Skin Creams Jump in Price

 OnBioVC
Stemgent, Inc.: Series C $6.3M

Genalyte, Inc.: Series A $11.8M

Relievant Medsystems, Inc.: Series D $30M

ImaginAb, Inc.: Series A $12.5M

BiO2 Medical, Inc.: Series B $13.7M

 Outsourcing-Pharma
Wockhardt targets CMO space for diversification

Overhaul of EU health systems good opportunity for outcomes data providers, says Quintiles

Home visits = regulatory thumbs up ResearchNurses.co thinks so

Home visits are the key to patient retention, says ResearchNurses.co

Kemwell and Boehringer set to finish biologics plant in India
Pharma News - Business Wire
IRIS International Selects ThingWorx for Next-Generation Remote Service and Support of Medical Devices

Growth in the Breast Cancer Drug Market Through 2021 Will Be Driven by New Entrants from Roche/Genentech and Novartis in Select Market Segments and an Increase in Incident Cases

Most Sales in the Parkinson's Disease Drug Market Will Continue to Be Driven by the Leading Dopamine Agonists Pramipexole and Ropinirole Coupled with the Reentry of UCB's Neupro/Leganto to the U.S. Market

Bio-Path Holdings Reports Second Quarter 2012 Operational and Financial Results

Renal Denervation Device Market to Grow Dramatically, but Physicians Will Still Consider Cost-Effective Tradeoffs When Making Purchase Decisions

 Pharma News - PharmiWeb
MRN posts 533% growth in first five years

North Highland Appoints Dr. Ricardo Martinez as Chief Medical Officer

Hospitals, Healthcare Providers to Benefit from New Premier Agreements for Wound Drainage Products

Charter Fitness to Open 14,000 Square-Foot Flagship Facility in Crystal Lake, IL

Newly Established Bestnet A/S Partnership Will Revolutionize Living Conditions for the World's Poorest Populations

 Pharma News - PR Newswire
Express Scripts Launches Virtual Coaching To Help Patients Better Understand Therapy

Nectid Announces Initiation Of Clinical Development Of Autism And Pain Drugs

Pharmacists United for Truth and Transparency Marks One Year Anniversary of Fighting Abuses by Pharmacy Benefits Managers

Medbox Safe Storage and Access Lockers Gaining Popularity

LipiGesic® M Fills the Need for Fast, Effective Migraine Treatment Described in the Wall Street Journal
Pharmaceutical - Moreover
: Pharmaceuticals look to cure pipeline concerns

Drug firms sign up to new tropical disease fight

Cannabis Science Presents Newest Photographs From 3rd Cancer Patient That Show Cancer Tumors Dying and Areas That Are No

Micro Labs attracts private equity and pharma interest: VCCircle

Novartis net dips by 5.3% to Rs.38 crore in Q3

 PR Leap - Biotech
Romer Labs Launches New Website

SHEL LAB Introduces the Bactrox Chamber

Abcam Launches Potent, Novel Dynamin Inhibitor Licensed from the University of Newcastle and Children's Medical Research Institute

Abcam Biochemicals is launched; the new name for Ascent Scientific products

AL-TAR Services, Inc. Adds Thermo-Scientific Product Line to its Online Lab Equipment Store

 PRWeb - Biotechnology
Global Human Growth Hormone Drugs Market to Reach US$4.7 Billion by...

Volpara Selected for Dutch Breast Screening MRI Trial

DuPont Tate & Lyle Bio Products Company Appoints Distributor of...

American Optometric Association (AOA) Debuts TrueVision® 3D...

Evolution Issue of the Month 4, Urging Evolutionists to Rethink...
PRWeb - Pharmaceuticals
Genomind Welcomes New Executive Team Member

Rising Health Consciousness Is Poised to Drive Growth in the Global...

Global and China Vitamin D3 2012 Market Report : Analysis and Trends

LA Kelley Communications, Inc., Announces the Winners of the Third...

The Herald-News in Illinois States that Jury in Vaughn Murder Trial to...

 Scientific American
Brain's Drain: Neuroscientists Discover Cranial Cleansing System

U.S. Swine Flu Outbreak Spikes

Climate Change Shaped Ancient Mummification Practices

Common Lab Dye Found to Interrupt Formation of Huntington's Disease Proteins

Prosthetic Retina Helps to Restore Sight in Mice

 Sports - ESPN Basketball
Nike schools commit to 16-team mega event

Muhammad won't travel to China on UCLA trip

Hoosiers recruit Patterson won't play at Indiana

Source: Recruit Patterson won't attend Indiana

Sources: Muhammad to sit out UCLA China trip
Sports News - ESPN
Experts: Ex-PSU president could still be charged

CSU wideout Coffman has emergency surgery

S. Carolina RB Lattimore strong in scrimmage

Texas A&M tabs freshman QB Manziel as starter

Pac-12 commish Scott: Coaches' poll a 'fallacy'

 Xconomy Life Sciences
Raising the Bar for Neuroscience in the Northwest

Biogen Idec, Regulus Cut Deal to Monitor Multiple Sclerosis

Richard Brewer, Former Scios CEO and Dendreon Chairman, Dies at 61

Bill Gates Turns His Attention, and Money, to Toilet Innovation

Renamed West Health Institute Names CEO, Creates Health Tech Incubator

 Yahoo Biotech News
Slow, costly process stymies generic biotech drugs (Reuters)

Analysis: Slow, costly process stymies generic biotech drugs (Reuters)

Waves Break Coral Embryo into Identical Twins (LiveScience.com)

Autoinjector Version of MS Drug Approved (HealthDay)

Fake Avastin had salt, starch, chemicals: Roche (Reuters)


SourceSolution © 2008-2012